Mary Riley serves as general counsel of DICE Therapeutics. Previously, she had 15-year tenure at Genentech, where she most recently served as vice president, litigation, where she served on the legal leadership team and was responsible for managing a wide range of legal matters. She also previously led Genentech’s business law group and employment law group, where she served as a member of the human resources leadership team. Before joining Genentech, Mary was a partner at Heller Ehrman LLP and held roles at other corporate law firms.
Mary holds a J.D. from Fordham University School of Law and a B.A. from College of the Holy Cross.